Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5701327 | European Journal of Surgical Oncology (EJSO) | 2016 | 19 Pages |
Abstract
Compared with LapTME, TaTME is a feasible and safe approach for patients with mid and low rectal cancer. In addition, TaTME showed a better short-term clinical outcomes, such as a longer CRM, lower risk of positive CRM, higher complete quality of TME rate, and shorter operative duration. Further prospective studies with long-term follow-up are required.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
W. Xu, Z. Xu, H. Cheng, J. Ying, F. Cheng, W. Xu, J. Cao, J. Luo,